Connection

Pilar Escribano Subías to Drug Resistance, Fungal

This is a "connection" page, showing publications Pilar Escribano Subías has written about Drug Resistance, Fungal.
  1. Is azole resistance in Aspergillus fumigatus a problem in Spain? Antimicrob Agents Chemother. 2013 Jun; 57(6):2815-20.
    View in: PubMed
    Score: 0.447
  2. Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis. Mycoses. 2019 May; 62(5):441-449.
    View in: PubMed
    Score: 0.168
  3. Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata. Med Mycol. 2018 Oct 01; 56(7):903-906.
    View in: PubMed
    Score: 0.163
  4. Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata Isolates. Antimicrob Agents Chemother. 2018 03; 62(3).
    View in: PubMed
    Score: 0.039
  5. Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia. Antimicrob Agents Chemother. 2017 07; 61(7).
    View in: PubMed
    Score: 0.037
  6. Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin. Antimicrob Agents Chemother. 2013 Nov; 57(11):5767-70.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.